Company GLOL BIOE Swiss Exchange

Equities

OXGBE

FR0011052257

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sector Other Advanced Medical Equipment & Technology

Inactive Instrument

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-

29/05	Global Bioenergies Announces Completion of the Basic Engineering Phase and Success of the Related Test Campaign	CI
09/04	Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	MT

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.

EUR in Million	Weight	2023	Weight	Delta
Isobutene 68.7 %	36.2 %	2	68.7 %	+783.58%
Services 27.5 %	43.8 %	1	27.5 %	+192.59%
Ancillary Activities 3.8 %	19.9 %	0	3.8 %	-12.35%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	1	100.0 %	3	100.0 %	+365.83%

Managers	Title	Age	Since
Marc Delcourt FOU	Founder	53	06/08/06
Samuel Dubruque DFI	Director of Finance/CFO	-	01/14/01
Frédéric Ollivier CTO	Chief Tech/Sci/R&D Officer	-	01/19/01
Bernard Chaud PRN	Corporate Officer/Principal	-	01/15/01
Alexandra Ramirez Moncada LAW	General Counsel	-	01/17/01
Martin Stephan PRN	Corporate Officer/Principal	-	19/23/19

Members of the board	Title	Age	Since
Pierre Levi BRD	Director/Board Member	69	18/19/18
Marc Delcourt FOU	Founder	53	06/08/06
Jean-Claude Lumaret BRD	Director/Board Member	66	18/01
Marie-Odile Lavenant BRD	Director/Board Member	58	02/22/02
Pierre Monsan BRD	Director/Board Member	75	28/21/28
Muriel Atias BRD	Director/Board Member	-	-
Corinne Granger CHM	Chairman	66	03/20/03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	11	18,128,860	15,233,947 ( 84.03 %)	7,265 ( 0.0401 %)	84.03 %

Name	Equities	%	Valuation
BOLD Business Opportunities For l'Oréal Development SASU 10.87 %	1,972,206	10.87 %	4 M €
OFI Invest Asset Management SA 2.393 %	434,000	2.393 %	844 577 €
Marc Delcourt 2.097 %	380,342	2.097 %	740 157 €
La Française Asset Management SAS 1.012 %	183,520	1.012 %	357 135 €
DNCA Finance SA 0.9975 %	180,943	0.9975 %	352 121 €
Friedland Gestion SAS 0.3230 %	58,593	0.3230 %	114 024 €
Uzes Gestion SA 0.2205 %	40,000	0.2205 %	77 841 €
GLOBAL BIOENERGIES 0.1075 %	19,496	0.1075 %	37 940 €
NOVACAP Asset Management SA 0.1021 %	18,528	0.1021 %	36 056 €
La Financière Desselligny SA 0.0451 %	8,174	0.0451 %	15 907 €

Name	Equities	%	Valuation
GLOBAL BIOENERGIES 0.11%	19,496	0.11%	37,940 $

Global Bioenergies SA

5, rue Henri Desbruères

91000, Evry

+33 1 64 98 20 50

http://www.global-bioenergies.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.29%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology